AstraZeneca granted exclusive worldwide licence to develop, manufacture and commercialise RQ Bio’s existing early-stage monoclonal antibodies (mAbs)…
Helping to progress an innovative gene therapy platform from the bench to a stage where it is progressing closer to the clinic.
Aims to transform the way diseases such as motor neurone disease are prevented, identified and treated.
10 innovative start-up companies working at the interface of biomedical and data science are to receive personalised…
LifeArc and partners announce a £13 million financing deal in Closed Loop Medicine to enable the company to develop further and faster.
A very warm welcome to three new Trustees who have joined our Board.
Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…
Funding to help drive the development of new cancer therapies